Asp-ase Activity of the Opossum Granzyme B Supports the Role of Granzyme B as Part of Anti-Viral Immunity Already during Early Mammalian Evolution

PLoS One. 2016 May 6;11(5):e0154886. doi: 10.1371/journal.pone.0154886. eCollection 2016.

Abstract

Granzyme B is one of the key effector molecules in our defense against viruses and intracellular bacteria. This serine protease together with the pore forming protein perforin, induces caspase or Bid-dependent apoptosis in target cells. Here we present the first characterization of a granzyme B homolog, the grathepsodenase, in a non-placental mammal, the American opossum (Monodelphis domestica). The recombinant enzyme was produced in a human cell line and used to study its primary and extended cleavage specificity using a panel of chromogenic substrates and recombinant protein substrates. The opossum granzyme B was found to have a specificity similar to human granzyme B, although slightly less restrictive in its extended specificity. The identification of a granzyme B homolog with asp-ase (cleaving after aspartic acid) specificity in a non-placental mammal provides strong indications that caspase or Bid-dependent apoptosis by a serine protease with a conserved primary specificity has been part of anti-viral immunity since early mammalian evolution. This finding also indicates that an asp-ase together with a chymase were the first two serine protease genes to appear in the mammalian chymase locus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Aspartic Acid / metabolism*
  • Biological Evolution*
  • Enzyme Activation
  • Granzymes / classification
  • Granzymes / metabolism*
  • Humans
  • Mice
  • Opossums
  • Phylogeny
  • Recombinant Proteins / metabolism
  • Sequence Homology, Amino Acid
  • Serpins / chemistry
  • Substrate Specificity
  • Virus Diseases / immunology
  • Virus Diseases / prevention & control*

Substances

  • Recombinant Proteins
  • Serpins
  • Aspartic Acid
  • Granzymes

Grants and funding

Funding provided by the Swedish National Research Council (Vetenskapsrådet-NT), 621-2011-5007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.